No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
LCTX Lineage Cell Therapeutics
- 1.020
- -0.100-8.93%
Close Jul 24 16:00 ET
- 1.010
- -0.010-0.98%
Post 16:23 ET
192.60MMarket Cap-7846P/E (TTM)
1.080High1.000Low796.71KVolume1.070Open1.120Pre Close832.48KTurnover0.54%Turnover RatioLossP/E (Static)188.82MShares1.61052wk High2.66P/B149.26MFloat Cap0.83752wk Low--Dividend TTM146.33MShs Float78.000Historical High--Div YieldTTM7.14%Amplitude0.100Historical Low1.044Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Lineage Cell Therapeutics Added to Membership of 2024 Russell 3000 Index
Lineage Cell Therapeutics(LCTX.US) Officer Buys US$10,500 in Common Stock
Express News | Lineage Cell Therapeutics Inc: Prospectus Related to Offer of Common Shares From Time to Time Having Offering Price of up to $40.0 Mln Through Agent
Lineage Cell Therapeutics Q1 2024 Earnings: Aligns With EPS Projections Amidst Revenue Declines
Earnings Call Summary | Lineage Cell Therapeutics(LCTX.US) Q1 2024 Earnings Conference
Lineage Cell Therapeutics Q1 2024 GAAP EPS $(0.04), Inline, Sales $1.444M Beat $1.359M Estimate
Comments
$Lineage Cell Therapeutics(LCTX.US$ reason it is moving up slowly… com/f/176343/x/...
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Green Dragon 2024OP : Because it’s biotech stock that no one knows about yet